EVOKE PHARMA, INC. Accounts Receivable
EVOKE PHARMA, INC. had Accounts Receivable of $1.23 million as of 2023-09-30, per its 10-K/A filed 2024-05-14.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:AccountsReceivableNetCurrent · last filed 2024-05-14
- 2023-09-30: Accounts Receivable, after Allowance for Credit Loss, Current $1.23M.
- 2023-06-30: Accounts Receivable, after Allowance for Credit Loss, Current $1.02M.
| Period end | Accounts Receivable, after Allowance for Credit Loss, Current |
|---|---|
| 2023-09-30 | $1.23M 10-K/A · filed 2024-05-14 |
| 2023-06-30 | $1.02M 10-K/A · filed 2024-05-14 |